Markets:

Overview

News

Currencies

International

Treasuries

Concert Pharmaceuticals, Inc. - Common Stock (NQ:CNCE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 3, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Concert Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Concert Pharma Aces Second Trial For Patchy Hair Loss Hopeful ↗

August 01, 2022

Via Benzinga

Concert Pharmaceuticals Reports Positive Topline Results for Second CTP‑543 Phase 3 Clinical Trial in Alopecia Areata

August 01, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022

July 29, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharma's CTP-543 Shows Clinical Efficacy Against Scalp Hair Loss ↗

May 23, 2022

Via Benzinga

Lilly-Incyte Snag FDA Nod For Patchy Hair Loss Treatment — Smaller Rival's Stock Shoots Up In Sympathy ↗

June 14, 2022

Alopecia areata, an autoimmune disorder that causes patchy hair loss, now has a new treatment that has been approved by the Food and Drug Administration.

Via Benzinga

Concert Pharmaceuticals to Participate in Fireside Chat at The JMP Securities Life Sciences Conference

June 09, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Phase 2 Dose‑Ranging Clinical Trial Results of CTP‑543 in Patients with Alopecia Areata published in the Journal of the American Academy of Dermatology

June 07, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharmaceuticals Raises Gross Proceeds of $66.4 Million Through Public Offering and Exercise of Warrants

June 06, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

74 Biggest Movers From Yesterday ↗

June 03, 2022

Gainers

Via Benzinga

53 Stocks Moving In Thursday's Mid-Day Session ↗

June 02, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 02, 2022

Via Benzinga

Concert Pharmaceuticals Announces Pricing of Public Offering

June 01, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

62 Biggest Movers From Yesterday ↗

June 02, 2022

Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Drops 100 Points; Concert Pharmaceuticals Shares Plummet ↗

June 01, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping 100 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 01, 2022

Via Benzinga

Mid-Day Market Update: Dow Dips 200 Points; Tonix Pharmaceuticals Shares Spike Higher ↗

June 01, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Wednesday.

Via Benzinga

44 Stocks Moving In Wednesday's Mid-Day Session ↗

June 01, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 01, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 01, 2022

Good morning, investors! Busy traders are already at work this morning as we go over the biggest pre-market stock movers for Wednesday.

Via InvestorPlace

18 Stocks Moving in Wednesday's Pre-Market Session ↗

June 01, 2022

Gainers Endo International plc (NASDAQ: ENDP) rose 46.1% to $0.7710 in pre-market trading after gaining over 12% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 31, 2022

Gainers

Via Benzinga

Concert Pharmaceuticals Announces Proposed Public Offering of Common Stock

May 31, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

70 Biggest Movers From Friday ↗

May 31, 2022

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 27, 2022

Gainers

Via Benzinga

20 Stocks Moving in Friday's Pre-Market Session ↗

May 27, 2022

Gainers Adicet Bio, Inc. (NASDAQ: ACET) rose 16% to $11.90 in pre-market trading after reporting positive clinical update from ADI-001 Phase 1 Trial in relapsed/refractory Non-Hodgkin’s Lymphoma.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 26, 2022

Via Benzinga

The Analyst Says 'Impressive Phase 3 Data Highlight Best-In-Class Opportunity' For Concert Pharma ↗

May 23, 2022

Via Benzinga

Concert Pharmaceuticals Reports Positive Topline Results for First CTP-543 Phase 3 Clinical Trial in Alopecia Areata

May 23, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Mizuho Sees Relief For This Small-Cap Stock After Patent Legal Overhang Lifted ↗

May 13, 2022

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 13, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Concert Pharmaceuticals, Inc. - Common Stock (NQ:CNCE)

All News about Concert Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today